Cannabidiol Shows Potential as Psychosis Treatment

In a group of young people at high risk of psychosis, a single dose of the cannabis extract cannabidiol (CBD) reduced brain function abnormalities in regions implicated in psychosis, according to a study published online inĀ JAMA Psychiatry.

The double-blind trial included 33 people who were experiencing psychotic symptoms but were not yet diagnosed with psychosis, along with 19 healthy control individuals. Among the participants at high risk of psychosis, 16 were randomized to receive a single dose of oral CBD and 17 to placebo. Participants who served as control subjects did not receive any drug.

Read The Rest of This Article Here!

Leave a Reply

Your email address will not be published. Required fields are marked *